Cormorant Asset Management’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $3.67M | Sell |
|
|||||
|
2018
Q4 | $4.3M | Sell |
|
|||||
|
2018
Q3 | $5.38M | Sell |
|
|||||
|
2018
Q2 | $7.42M | Hold |
|
|||||
|
2018
Q1 | $5.28M | Sell |
|
|||||
|
2017
Q4 | $3.62M | Sell |
|
|||||
|
2017
Q3 | $9.21M | Hold |
|
|||||
|
2017
Q2 | $7.89M | Sell |
|
|||||
|
2017
Q1 | $18M | Sell |
|
|||||
|
2016
Q4 | $25.6M | Buy |
|
|||||
|
2016
Q3 | $30.5M | Hold |
|
|||||
|
2016
Q2 | $32M | Buy |
|
|||||
|
2016
Q1 | $33.2M | Buy |
|
|||||
|
2015
Q4 | $45M | Hold |
|
|||||
|
2015
Q3 | $41.1M | Buy |
|
|||||
|
2015
Q2 | $44.9M | Buy |
|
|||||
|
2015
Q1 | $18.5M | Buy |
|
|||||
|
2014
Q4 | $7.04M | Hold |
|
|||||
|
2014
Q3 | $5.83M | Hold |
|
|||||
|
2014
Q2 | $8.62M | Buy |
|